Individual results vary widely, and some users experience no noticeable benefits
Is it mostly skin, mostly fat, or both
Not one of them has human trial evidence for the systemic, injected, combination use that KLOW, GLOW, and Wolverine represent
Retatrutide activates GLP-1 receptors throughout the gastrointestinal tract, altering gut motility and gastric emptying
Body composition: DEXA scan or bioimpedance every 2 to 3 months to track fat loss versus muscle retention
When demand for GLP-1s and GIP/GLP-1s leaped past what the manufacturers could provide, compounded versions popped up in online pharmacies and brick-and-mortar stores, for the following drugs: Ozempic (semaglutide) Rybelsus (semaglutide) Wegovy (semaglutide) Zepbound (tirzepatide) Mounjaro (tirzepatide) Retatrutide (This drug is not FDA approved.) However, the FDA cautions that compounded drugs, while useful or even necessary in some situations, are not FDA-reviewed or approved, so the FDA cannot guarantee their safety, quality, or effectiveness
